CD4 and rheumatoid arthritis: TNF-α treatment enhances the expression of SLAP in the CD4+ T-lymphocytes of healthy donors and DMARD treated RA patients but does not alter the expression of CD4+ T-cells isolated from biological DMARD (etanercept, certolizumab pegol) treated patients [47].